Sildenafil citrate and uteroplacental perfusion in fetal growth restriction

BACKGROUND: To determine whether the phosphodiesterase type 5 inhibitor, Sildenafil citrate, affects uteroplacental perfusion. MATERIALS AND METHODS: Based on a randomized double-blinded and placebo-controlled trial, forty one pregnant women with documented intrauterine growth retardation at 24-37 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dastjerdi, Marzieh Vahid, Hosseini, Sayedehafagh, Bayani, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685778/
https://www.ncbi.nlm.nih.gov/pubmed/23798922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685778/
https://www.ncbi.nlm.nih.gov/pubmed/23798922

Ejemplares similares